Moderna tops fourth quarter revenue estimates on strong vaccine sales
Moderna reported fourth-quarter revenue of 678 million dollars on Friday. The results exceeded analyst expectations due to strong vaccine sales in the U.S.
Insights:
Moderna, Inc. reported fourth-quarter revenue of $678 million on February 13, 2026, exceeding the LSEG-compiled Wall Street average estimate of $626.1 million. The company’s financial performance for the period was driven by better-than-expected COVID-19 vaccine sales in the US 
US, which resulted in a significant revenue beat relative to market projections.
US, which resulted in a significant revenue beat relative to market projections.
